The highest estimate is 42.00. From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow BCAX.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Bicara Therapeutics Inc. is a subsidiary of Biocon Limited.
The current price of BCAX.BOATS is $18.45 USD — it has decreased by -5.67% in the past 24 hours. Watch Bicara Therapeutics stock price performance more closely on the chart.
What is Bicara Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bicara Therapeutics stocks are traded under the ticker BCAX.BOATS.
What is Bicara Therapeutics market cap?▼
Today Bicara Therapeutics has the market capitalization of 1.01B
When is the next Bicara Therapeutics earnings date?▼
Bicara Therapeutics is going to release the next earnings report on May 19, 2026.
What is Bicara Therapeutics revenue for the last year?▼
Bicara Therapeutics revenue for the last year amounts to 0 USD.
What is Bicara Therapeutics net income for the last year?▼
BCAX.BOATS net income for the last year is -100.56M USD.
When did Bicara Therapeutics complete a stock split?▼
Bicara Therapeutics has not had any recent stock splits.